124 related articles for article (PubMed ID: 17885628)
21. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.
Tumer TB; Ulusoy G; Adali O; Sahin G; Gozdasoglu S; Arinç E
Am J Hematol; 2007 Oct; 82(10):906-10. PubMed ID: 17617792
[TBL] [Abstract][Full Text] [Related]
22. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
Song DK; Zhao J; Zhang LR
J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of 23 allelic variants of thiopurine S-methyltransferase gene (TPMT*2 - *24).
Ujiie S; Sasaki T; Mizugaki M; Ishikawa M; Hiratsuka M
Pharmacogenet Genomics; 2008 Oct; 18(10):887-93. PubMed ID: 18708949
[TBL] [Abstract][Full Text] [Related]
24. Mistaken identity: misclassification of TPMT phenotype following blood transfusion.
Cheung ST; Allan RN
Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1245-7. PubMed ID: 14560161
[TBL] [Abstract][Full Text] [Related]
25. Thiopurine S-methyltransferase genetic polymorphism in the Thai population.
Srimartpirom S; Tassaneeyakul W; Kukongviriyapan V; Tassaneeyakul W
Br J Clin Pharmacol; 2004 Jul; 58(1):66-70. PubMed ID: 15206995
[TBL] [Abstract][Full Text] [Related]
26. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
[TBL] [Abstract][Full Text] [Related]
27. Rapid, long-range molecular haplotyping of thiopurine S-methyltransferase (TPMT) *3A, *3B, and *3C.
von Ahsen N; Armstrong VW; Oellerich M
Clin Chem; 2004 Sep; 50(9):1528-34. PubMed ID: 15247157
[TBL] [Abstract][Full Text] [Related]
28. Insight into TPMT(∗)23 mutation mis-folding using molecular dynamics simulation and protein structure analysis.
Larif S; Ben Salem C; Soua Z; Hmouda H; Bouraoui K
J Biomol Struct Dyn; 2013 Oct; 31(10):1066-76. PubMed ID: 23025308
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive study of thiopurine methyltransferase genotype, phenotype, and genotype-phenotype discrepancies in Sweden.
Zimdahl Kahlin A; Helander S; Skoglund K; Söderkvist P; Mårtensson LG; Appell ML
Biochem Pharmacol; 2019 Jun; 164():263-272. PubMed ID: 31005613
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of the thiopurine S-methyltransferase alleles in Bolivians and Tibetans.
Lu HF; Shih MC; Hsueh SC; Chen CM; Chang JY; Chang JG
J Clin Pharm Ther; 2005 Oct; 30(5):491-6. PubMed ID: 16164497
[TBL] [Abstract][Full Text] [Related]
31. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
Winter JW; Gaffney D; Shapiro D; Spooner RJ; Marinaki AM; Sanderson JD; Mills PR
Aliment Pharmacol Ther; 2007 May; 25(9):1069-77. PubMed ID: 17439508
[TBL] [Abstract][Full Text] [Related]
32. Determination of thiopurine S-methyltransferase (TPMT) activity by comparing various normalization factors: reference values for Estonian population using HPLC-UV assay.
Oselin K; Anier K; Tamm R; Kallassalu K; Mäeorg U
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Apr; 834(1-2):77-83. PubMed ID: 16517227
[TBL] [Abstract][Full Text] [Related]
33.
Mora Y; Villegas C; Mora YM; Moreno N
Pharmacogenomics; 2023 Mar; 24(4):219-225. PubMed ID: 36946340
[No Abstract] [Full Text] [Related]
34. Genotyping of thiopurine methyltransferase using pyrosequencing.
Okada Y; Nakamura K; Wada M; Nakamura T; Tsukamoto N; Nojima Y; Horiuchi R; Yamamoto K
Biol Pharm Bull; 2005 Apr; 28(4):677-81. PubMed ID: 15802809
[TBL] [Abstract][Full Text] [Related]
35. Analysis of ITPA phenotype-genotype correlation in the Bulgarian population revealed a novel gene variant in exon 6.
Atanasova S; Shipkova M; Svinarov D; Mladenova A; Genova M; Wieland E; Oellerich M; von Ahsen N
Ther Drug Monit; 2007 Feb; 29(1):6-10. PubMed ID: 17304144
[TBL] [Abstract][Full Text] [Related]
36. Genetic analyses of thiopurine methyltransferase polymorphisms in Greenlandic and Danish populations.
Toft N; Nygaard U; Gregers J; Schmiegelow K
Acta Paediatr; 2006 Dec; 95(12):1665-7. PubMed ID: 17129980
[TBL] [Abstract][Full Text] [Related]
37. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
Brouwer C; De Abreu RA; Keizer-Garritsen JJ; Lambooy LH; Ament K; ter Riet PG; van Wering ER; Trijbels FJ; Veerman AJ; Hoogerbrugge PM; Bökkerink JP
Eur J Cancer; 2005 Mar; 41(4):613-23. PubMed ID: 15737567
[TBL] [Abstract][Full Text] [Related]
38. Using HapMap tools in pharmacogenomic discovery: the thiopurine methyltransferase polymorphism.
Jones TS; Yang W; Evans WE; Relling MV
Clin Pharmacol Ther; 2007 May; 81(5):729-34. PubMed ID: 17329987
[TBL] [Abstract][Full Text] [Related]
39. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?
Fakhoury M; Andreu-Gallien J; Mahr A; Medard Y; Azougagh S; Vilmer E; Jacqz-Aigrain E
J Clin Pharm Ther; 2007 Dec; 32(6):633-9. PubMed ID: 18021342
[TBL] [Abstract][Full Text] [Related]
40. Thiopurine S-methyltransferase pharmacogenetics: variant allele functional and comparative genomics.
Salavaggione OE; Wang L; Wiepert M; Yee VC; Weinshilboum RM
Pharmacogenet Genomics; 2005 Nov; 15(11):801-15. PubMed ID: 16220112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
